The U.S. Food and Drug Administration (FDA) has approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications. Read more.

FDA approves medical device for epilepsy

C-suite executives believe ACA will improve health care

Study: Roles and responsibilities of patient navigators defined

Blood pressure management guideline released

Study: Nonconcussion head impacts may affect cognition

BSN, MSN graduates more likely to land jobs

Study: No same-day play for athletes with concussion symptoms

Study: Distracted driving more lethal

Study: Insomnia may increase mortality

Leading at the bedside and beyond

From our readers: My first code—A retrospective report of a premature promotion and a crisis situation

From our readers: What it means to be a nurse

Amazing apps: Space-age tools for clinicians

Many shades of grey

National Magnet Nurse of the Year® 2013 Award Winners

Exposed to patient’s body fluids? Now what?

Preventing complications in patients receiving opioids

Nursing leaders hold the key to translating genomics into practice

Learn about the five constructs of the healthy nurse.

Let there be peace

Don’t get ‘caught’ in the CAUTI trap

Detecting, managing, and preventing pulmonary embolism

Welcome to American Nurse

Quiz time

Study: Natural compound may block effects of methamphetamine

FDA allows marketing of ‘next generation’ gene sequencing devices

New intravaginal ring

FDA approves Gazyva for chronic lymphocytic leukemia

ACE inhibitors and acute kidney injury

FDA approves extended-release, single-entity hydrocodone product

Study: Atrial fib hospitalizations, costs soar in U.S.

Study: Cooling temperature for therapeutic hypothermia

Study: Decreased sepsis mortality

Study: Despite increased resources, US lags in health outcomes

Independent NP practice in retail clinics saves money

Four new guidelines from AHA, ACC